Corvus Pharmaceuticals Inc (CRVS)
1.72
+0.11
(+6.83%)
USD |
NASDAQ |
May 02, 16:00
1.72
0.00 (0.00%)
After-Hours: 18:39
Corvus Pharmaceuticals Accounts Payable (Quarterly): 1.525M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.525M |
September 30, 2023 | 1.404M |
June 30, 2023 | 2.098M |
March 31, 2023 | 1.407M |
December 31, 2022 | 1.976M |
September 30, 2022 | 4.227M |
June 30, 2022 | 2.65M |
March 31, 2022 | 2.189M |
December 31, 2021 | 1.565M |
September 30, 2021 | 2.334M |
June 30, 2021 | 2.865M |
March 31, 2021 | 4.91M |
December 31, 2020 | 3.467M |
September 30, 2020 | 2.571M |
June 30, 2020 | 2.779M |
March 31, 2020 | 3.356M |
December 31, 2019 | 2.448M |
Date | Value |
---|---|
September 30, 2019 | 1.91M |
June 30, 2019 | 2.638M |
March 31, 2019 | 2.264M |
December 31, 2018 | 1.998M |
September 30, 2018 | 1.885M |
June 30, 2018 | 2.255M |
March 31, 2018 | 3.499M |
December 31, 2017 | 3.454M |
September 30, 2017 | 3.576M |
June 30, 2017 | 4.138M |
March 31, 2017 | 2.421M |
December 31, 2016 | 1.90M |
September 30, 2016 | 2.416M |
June 30, 2016 | 1.32M |
March 31, 2016 | 1.577M |
December 31, 2015 | 1.575M |
September 30, 2015 | 0.447M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.404M
Minimum
Sep 2023
4.91M
Maximum
Mar 2021
2.543M
Average
2.448M
Median
Dec 2019
Accounts Payable (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 3.543M |
Arbutus Biopharma Corp | 3.223M |
Oragenics Inc | 1.245M |
Relmada Therapeutics Inc | 3.506M |
MAIA Biotechnology Inc | 1.638M |